This EVERSANA white paper highlights the importance of medical and scientific fact-checking in the Medical, Legal, and Regulatory (MLR) review process to ensure pharmaceutical communications are accurate, evidence-based, and compliant with global regulations. It explains how fact-checkers validate claims, references, and safety information before medical review, reducing regulatory risk, improving review efficiency, and accelerating product launches. The paper also outlines regulatory requirements, best practices, and a case study showing how rigorous fact-checking supported multiple product launches with over 99% accuracy, zero compliance findings, faster review cycles, and timely approvals while protecting patient safety and brand integrity.

Join for free to read